Recent advances in polymeric microspheres for parenteral drug delivery – part 1

Introduction: Polymeric microspheres have been established as a valuable parenteral drug delivery system for sustained release of therapeutic agents via subcutaneous or intramuscular injection. Areas covered: Biodegradable polymers which are either synthetic or from natural sources are reviewed with respect to recent advances in exploring their applications for microsphere fabrications. New information on the impact of formulation variables on the properties of microspheres formed by an emulsion method was also presented. The characterization of microspheres using advanced physical analytical techniques was also reviewed and the utilization of the information in assessing in vivo performance of the product was also highlighted. Expert opinion: The broad clinical use of microspheres for delivery of therapeutic agents in particular biologics such as proteins has not been realized commercially. The limited availability of biodegradable polymers with a long history of regulatory approval and the challenges in gaining regulatory approval of a new polymer have hindered the development of microspheres for parenteral drug delivery.

[1]  Sudhir S Chakravarthi,et al.  Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. , 2011, International journal of pharmaceutics.

[2]  T. Park,et al.  Gas foamed open porous biodegradable polymeric microspheres. , 2006, Biomaterials.

[3]  Shin Jung,et al.  Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. , 2003, International journal of pharmaceutics.

[4]  A. G. Ding,et al.  Acidic Microclimate pH Distribution in PLGA Microspheres Monitored by Confocal Laser Scanning Microscopy , 2008, Pharmaceutical Research.

[5]  T. Coviello,et al.  Recent advances and perspectives on coated alginate microspheres for modified drug delivery. , 2008, Expert opinion on drug delivery.

[6]  A. Szabó,et al.  A DSC and Raman spectroscopic study of microspheres preparedwith polar cosolvents by different techniques , 2008 .

[7]  S. Feng,et al.  Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. , 2003, Biomaterials.

[8]  A. Lamprecht,et al.  Structural analysis of microparticles by confocal laser scanning microscopy , 2000, AAPS PharmSciTech.

[9]  Hanry Yu,et al.  Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. , 2003, Biomaterials.

[10]  Weiliam Chen,et al.  Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.

[11]  F. Mi,et al.  Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. , 2003, Biomaterials.

[12]  Yi Yan Yang,et al.  Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method , 2000 .

[13]  A. Wan,et al.  A new nerve guide conduit material composed of a biodegradable poly(phosphoester). , 2001, Biomaterials.

[14]  V. B. Konkimalla,et al.  Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Lukchiu Li,et al.  In Vitro Characterization of Polyorthoester Microparticles Containing Bupivacaine , 2003, Pharmaceutical development and technology.

[16]  B. Gander,et al.  Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Hans P Merkle,et al.  Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.

[18]  M. Ercan,et al.  Formulation and Characterization of Formaldehyde Cross-linked Degradable Starch Microspheres Containing Terbutaline Sulfate , 2007, Drug development and industrial pharmacy.

[19]  C T Laurencin,et al.  Toxicity, biodegradation and elimination of polyanhydrides. , 2002, Advanced drug delivery reviews.

[20]  G. Ruan,et al.  Effects of polymer, organic solvent and mixing strength on integrity of proteins and liposomes encapsulated in polymeric microspheres fabricated by the double emulsion process , 2004, Journal of microencapsulation.

[21]  R. Kaushik,et al.  Poly-epsilon-caprolactone microspheres and nanospheres: an overview. , 2004, International journal of pharmaceutics.

[22]  Raju Adhikari,et al.  Recent developments in biodegradable synthetic polymers. , 2006, Biotechnology annual review.

[23]  R. K. Khar,et al.  Tetanus toxoid loaded 'preformed microspheres' of cross-linked dextran. , 2001, Vaccine.

[24]  W. W. Barrow Microsphere technology for chemotherapy of mycobacterial infections. , 2004, Current pharmaceutical design.

[25]  Yanfei Liu,et al.  Preparation of novel polymeric microspheres for controlled release of finasteride. , 2007, International journal of pharmaceutics.

[26]  M. D. Blanco,et al.  Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres , 2010 .

[27]  F. Alexis Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] , 2005 .

[28]  Mario Malinconico,et al.  Poly (D,L-lactic acid)/poly (∈-caprolactone) blend membranes: preparation and morphological characterisation , 2000 .

[29]  Yufeng Zheng,et al.  Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold , 2011 .

[30]  C. Sturesson,et al.  Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Qiang Zhang,et al.  Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[32]  N. Nitta,et al.  Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. , 2008, European journal of radiology.

[33]  W. L. Hunter,et al.  Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits , 2004, Inflammation Research.

[34]  K. Leong,et al.  Polyphosphoesters in drug and gene delivery. , 2003, Advanced drug delivery reviews.

[35]  H. Sah Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres. , 2000, International journal of pharmaceutics.

[36]  Dariusz Stramski,et al.  Measurements and characterization of particle size distributions in coastal waters , 2010 .

[37]  Robert Gurny,et al.  Poly(ortho esters): synthesis, characterization, properties and uses. , 2002, Advanced drug delivery reviews.

[38]  R. Kato,et al.  Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases , 2005, Journal of Gastrointestinal Surgery.

[39]  P. Noble,et al.  Hyaluronan as an immune regulator in human diseases. , 2011, Physiological reviews.

[40]  G. Gee,et al.  Particle-size Analysis , 2018, SSSA Book Series.

[41]  R. Heeren,et al.  Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[42]  R. Herrero-Vanrell,et al.  Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Hans P Merkle,et al.  Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[44]  A. Szabó,et al.  An assessment of the interactions between diclofenac sodium and ammonio methacrylate copolymer using thermal analysis and Raman spectroscopy. , 2008, Journal of pharmaceutical and biomedical analysis.

[45]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[46]  R. Kaushik,et al.  Poly-ϵ-caprolactone microspheres and nanospheres: an overview , 2004 .

[47]  P. Ramesh,et al.  Preparation of microstructured hydroxyapatite microspheres using oil in water emulsions , 2005 .

[48]  V. Guarino,et al.  Engineering of poly(ε-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic , 2008 .

[49]  You-Xin Li,et al.  Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. , 2006, International journal of pharmaceutics.

[50]  T. Park,et al.  Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. , 2004, International journal of pharmaceutics.

[51]  S. Lakshmi,et al.  A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[52]  S. Schwendeman,et al.  Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. , 2004, Biomaterials.

[53]  Shirui Mao,et al.  Recent advances in polymeric microspheres for parenteral drug delivery—part 2 , 2012, Expert opinion on drug delivery.

[54]  H. Lee,et al.  Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. , 2002, International journal of pharmaceutics.

[55]  Qing Ge,et al.  Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines , 2004, Nature materials.

[56]  J. Swarbrick,et al.  Encyclopedia of Pharmaceutical Technology , 2006 .

[57]  Shufen Ma,et al.  Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. , 2011, International journal of pharmaceutics.

[58]  R. Herrero-Vanrell,et al.  Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. , 2004, International journal of pharmaceutics.

[59]  M. Tafaghodi,et al.  Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. , 2006, International journal of pharmaceutics.

[60]  R. Kaushik,et al.  Chitosan microspheres as a potential carrier for drugs. , 2004, International journal of pharmaceutics.

[61]  Wenlei Jiang,et al.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres. , 2008, Molecular pharmaceutics.

[62]  X. Mei,et al.  Development of interferon alpha-2b microspheres with constant release. , 2011, International journal of pharmaceutics.

[63]  Abraham J Domb,et al.  Polyanhydrides: an overview. , 2002, Advanced drug delivery reviews.

[64]  Felice Cheng,et al.  The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain. , 2011, Biomaterials.

[65]  Rajeev Bhat,et al.  Gelatin alternatives for the food industry: recent developments, challenges and prospects , 2008 .

[66]  H. Chung,et al.  Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[67]  A. Schaper,et al.  Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA , 2009, Journal of microencapsulation.

[68]  Anthony J. Hickey,et al.  Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia , 2004, The AAPS Journal.

[69]  Sweta Modi,et al.  Role of polyanhydrides as localized drug carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Xiaoyuan Chen,et al.  PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[71]  Qing Yang,et al.  Biodegradable Progesterone Microsphere Delivery System for Osteoporosis Therapy , 2000, Drug development and industrial pharmacy.

[72]  T. Aminabhavi,et al.  Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. , 2007, Journal of Controlled Release.

[73]  R. Zhuo,et al.  Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics. , 2011, Colloids and surfaces. B, Biointerfaces.

[74]  W. Hennink,et al.  Degradable dextran microspheres for the controlled release of liposomes. , 2001, International journal of pharmaceutics.

[75]  T. Kissel,et al.  Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique , 2000, Journal of microencapsulation.

[76]  T. Park,et al.  Fabrication of Adipose-Derived Mesenchymal Stem Cell Aggregates using Biodegradable Porous Microspheres for Injectable Adipose Tissue Regeneration , 2011, Journal of biomaterials science. Polymer edition.

[77]  P. Weston,et al.  Effect of protein molecular weight on release from micron-sized PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Steven P Schwendeman,et al.  BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. , 2006, Journal of pharmaceutical sciences.

[79]  E. Chiellini,et al.  Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. , 2008, Nanomedicine.

[80]  T. Nagai,et al.  Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[81]  H. Abe,et al.  Poly(lactide-co-glycolide) encapsulated hydroxyapatite microspheres for sustained release of doxycycline , 2012 .

[82]  C. Laurencin,et al.  Synthesis, characterization of chitosans and fabrication of sintered chitosan microsphere matrices for bone tissue engineering. , 2007, Acta biomaterialia.

[83]  S. Srirangarajan,et al.  Development and evaluation of novel biodegradable microspheres based on poly(D,L-lactide-co-glycolide) and poly(ε-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket : In vitro and in vivo studies , 2007 .

[84]  G. Rose,et al.  A molecular mechanism for osmolyte-induced protein stability , 2006, Proceedings of the National Academy of Sciences.

[85]  J. Emami,et al.  The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. , 2009, Colloids and surfaces. B, Biointerfaces.

[86]  T. Kissel,et al.  Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[87]  C. Gamazo,et al.  In vitro evaluation of gentamicin released from microparticles. , 2002, International journal of pharmaceutics.

[88]  L. Leondiadis,et al.  PLA and PLGA microspheres of beta-galactosidase: Effect of formulation factors on protein antigenicity and immunogenicity. , 2004, Journal of biomedical materials research. Part A.

[89]  P. V. van Rijk,et al.  Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. , 2002, Current medicinal chemistry.

[90]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[91]  Yi Yan Yang,et al.  Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. , 2001, Biomaterials.

[92]  M. Amiji,et al.  Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. , 2002, International journal of pharmaceutics.

[93]  K. Öğe,et al.  Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats , 2003, Acta anaesthesiologica Scandinavica.

[94]  S. Moochhala,et al.  Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. , 2004, Biomaterials.

[95]  J. Xu,et al.  Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. , 2007, International journal of pharmaceutics.

[96]  W. Hennink,et al.  Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation , 2007, Pharmaceutical Research.

[97]  Ben Forbes,et al.  Hyaluronan: Pharmaceutical Characterization and Drug Delivery , 2005, Drug delivery.

[98]  Rajesh Kumar,et al.  Points to Consider when Establishing Drug Product Specifications for Parenteral Microspheres , 2010, The AAPS Journal.

[99]  J. Xu,et al.  Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[100]  Wei Sun,et al.  Chitosan-based formulations for delivery of DNA and siRNA. , 2010, Advanced drug delivery reviews.

[101]  X. Wu,et al.  Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres , 2003, The Journal of pharmacy and pharmacology.

[102]  T. Misawa,et al.  Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats. , 2006, The Journal of surgical research.

[103]  D. Irvine,et al.  Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. , 2008, Acta biomaterialia.

[104]  Diane J. Burgess,et al.  Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[105]  S. Feng,et al.  Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[106]  Xian‐Zheng Zhang,et al.  Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-α,β-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers , 2008 .

[107]  Olivier Rouaud,et al.  Microencapsulation by solvent evaporation: state of the art for process engineering approaches. , 2008, International journal of pharmaceutics.

[108]  C T Laurencin,et al.  Biodegradable polyphosphazenes for drug delivery applications. , 2003, Advanced drug delivery reviews.

[109]  J. Lanciego,et al.  Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[110]  A. Gupte,et al.  Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. , 2004, International journal of pharmaceutics.

[111]  A. Ludwig,et al.  Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. , 2002, International journal of pharmaceutics.

[112]  T. Volova,et al.  Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation , 2008, Journal of materials science. Materials in medicine.